{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:34Z","timestamp":1790393614627,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007465","name":"Universitetet i Troms\u00f8","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejmech.2022.114632","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T11:25:54Z","timestamp":1659698754000},"page":"114632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A concise SAR-analysis of antimicrobial cationic amphipathic barbiturates for an improved activity-toxicity profile"],"prefix":"10.1016","volume":"241","author":[{"given":"Manuel K.","family":"Langer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hymonti","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trude","family":"Anderssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zilioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Matti","family":"Blencke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Stensv\u00e5g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten B.","family":"Str\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-200X","authenticated-orcid":false,"given":"Annette","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114632_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib2","series-title":"Global Action Plan on Antimicrobial Resistance","year":"2015"},{"key":"10.1016\/j.ejmech.2022.114632_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114632_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/femsre\/fuz014","article-title":"Antibiotic resistance breakers: current approaches and future directions","volume":"43","author":"Laws","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114632_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00105","article-title":"Challenges and future prospects of antibiotic therapy: from peptides to phages utilization","volume":"5","author":"Mandal","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114632_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1039\/b311900a","article-title":"Photodynamic therapy: a new antimicrobial approach to infectious disease?","volume":"3","author":"Hamblin","year":"2004","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.ejmech.2022.114632_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2015.07.014","article-title":"Antibacterial monoclonal antibodies: the next generation?","volume":"27","author":"DiGiandomenico","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib8","article-title":"Alternative antimicrobial approach: nano-antimicrobial materials","volume":"2015","author":"Beyth","year":"2015","journal-title":"Evid. base Compl. Alternative Med."},{"key":"10.1016\/j.ejmech.2022.114632_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib10","first-page":"79","article-title":"Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics","volume":"2","author":"Hancock","year":"2002","journal-title":"Curr. Drug Targets: Infect. Disord."},{"key":"10.1016\/j.ejmech.2022.114632_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.114632_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07388551.2011.594423","article-title":"Antimicrobial peptides: key components of the innate immune system","volume":"32","author":"Pasupuleti","year":"2012","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.114632_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2022.114632_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(97)80051-7","article-title":"Peptide antibiotics","volume":"349","author":"Hancock","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114632_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2005.11.004","article-title":"Cationic host defense (antimicrobial) peptides","volume":"18","author":"Brown","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2022.114632_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144611","article-title":"Comparative evaluation of the antimicrobial activity of different antimicrobial peptides against a range of pathogenic bacteria","volume":"10","author":"Ebbensgaard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114632_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114632_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/pj.2017.72","article-title":"Antimicrobial cationic polymers: from structural design to functional control","volume":"50","author":"Yang","year":"2018","journal-title":"Polym. J."},{"key":"10.1016\/j.ejmech.2022.114632_bib20","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mabi.201500207","article-title":"Nontoxic, hydrophilic cationic polymers\u2014identified as class of antimicrobial polymers","volume":"15","author":"Strassburg","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejmech.2022.114632_bib21","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1021\/ja0107475","article-title":"De novo design, synthesis, and characterization of antimicrobial \u03b2-peptides","volume":"123","author":"Liu","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114632_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2174\/1568026616666161018145945","volume":"17","author":"Sang","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/jm901052r","article-title":"Antimicrobial activity of small \u03b2-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides","volume":"53","author":"Hansen","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib24","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1039\/C7CC07285F","article-title":"Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential","volume":"53","author":"Teng","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2022.114632_bib25","doi-asserted-by":"crossref","first-page":"e3117","DOI":"10.1002\/psc.3117","article-title":"An amphipathic cyclic tetrapeptide scaffold containing halogenated \u03b22,2-amino acids with activity against multiresistant bacteria","volume":"24","author":"Paulsen","year":"2018","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejmech.2022.114632_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111671","article-title":"Antimicrobial activity of amphipathic \u03b1,\u03b1-disubstituted \u03b2-amino amide derivatives against ESBL \u2013 CARBA producing multi-resistant bacteria; effect of halogenation, lipophilicity and cationic character","volume":"183","author":"Paulsen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib27","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1021\/acs.jmedchem.1c00312","article-title":"Modular design of membrane-active antibiotics: from macromolecular antimicrobials to small scorpionlike peptidomimetics","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib28","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1021\/acs.jmedchem.1c00734","article-title":"Amphipathic barbiturates as mimics of antimicrobial peptides and the marine natural products eusynstyelamides with activity against multi-resistant clinical isolates","volume":"64","author":"Paulsen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/np900099j","article-title":"From the ascidian Eusynstyela latericius","volume":"72","author":"Tapiolas","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114632_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/np100499c","article-title":"The antibacterial ent-eusynstyelamide B and eusynstyelamides D, E, and F from the Arctic bryozoan Tegella cf. spitzbergensis","volume":"74","author":"Tadesse","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114632_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive compound accumulation rules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114632_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/acsinfecdis.0c00715","article-title":"Compound uptake into E. coli can Be facilitated by N-alkyl guanidiniums and pyridiniums","volume":"7","author":"Perlmutter","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114632_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3184\/030823409X460713","article-title":"Synthesis of a series of perfluoroalkyl containing spiro cyclic barbituric acid derivatives","volume":"2009","author":"Zhang","year":"2009","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114632_bib34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bmcl.2004.12.034","article-title":"Spiro-annulation of barbituric acid derivatives and its analogs by ring-closing metathesis reaction","volume":"15","author":"Kotha","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114632_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2014.01.002","article-title":"Barbituric acids as a useful tool for the construction of coordination and supramolecular compounds","volume":"265","author":"Mahmudov","year":"2014","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114632_bib36","series-title":"Adv. Heterocycl. Chem.","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2725(08)60921-6","article-title":"Recent progress in barbituric acid chemistry","author":"Bojarski","year":"1985"},{"key":"10.1016\/j.ejmech.2022.114632_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jhet.5570230103","article-title":"Preparation of 5-substituted benzylbarburituric acids and investigation of the effect of the benzyl and substituted benzyl groups on the acidity of barbituric acid","volume":"23","author":"Tate","year":"1986","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ejoc.200701014","article-title":"Development of pharmaceutical drugs, drug intermediates and ingredients by using direct organo-click reactions","volume":"2008","author":"Ramachary","year":"2008","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0036-1591725","article-title":"2-Phenyl-2,3-dihydrobenzo[d]thiazole: a mild, efficient, and highly active in situ generated chemoselective reducing agent for the one-pot synthesis of 5-monoalkylbarbiturates in water","volume":"29","author":"Kalita","year":"2018","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2022.114632_bib40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/00397919208021101","article-title":"Synthesis of oxadeazaflavines from barbituric acid and aromatic aldehydes","volume":"22","author":"Figueroa-Villar","year":"1992","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2022.114632_bib41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1039\/C5MD00187K","article-title":"Design, synthesis and in vivo evaluation of sodium 2-benzyl-chloromalonates as new central nervous system depressants","volume":"6","author":"Vieira","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2022.114632_bib42","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/C5QO00016E","article-title":"The Mitsunobu reaction in the 21st century","volume":"2","author":"Fletcher","year":"2015","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2022.114632_bib43","first-page":"49","article-title":"Recent developments in guanylating agents","volume":"2005","author":"Katritzky","year":"2005","journal-title":"Archive for Organic Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib44","first-page":"37","article-title":"Reagents for efficient conversion of amines to protected guanidines","volume":"2004","author":"Gers","year":"2004","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2022.114632_bib45","first-page":"73","article-title":"Antimicrobial peptides and their analogs: searching for new potential therapeutics","volume":"6","author":"Midura-Nowaczek","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/aem.55.4.832-836.1989","article-title":"Cell surface charge characteristics and their relationship to bacterial attachment to meat surfaces","volume":"55","author":"Dickson","year":"1989","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dkl011","article-title":"Resistance to a polyquaternium-1 lens care solution and isoelectric points of Pseudomonas aeruginosa strains","volume":"57","author":"Bruinsma","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114632_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0223-5234(97)83292-8","article-title":"Synthesis and antimicrobial activities of new quats","volume":"32","author":"Skrzypczak","year":"1997","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib49","first-page":"803","article-title":"Quaternary ammonium-salts. 18. Preparation and relationship between structure, IR spectral characteristics, and antimicrobial activity of some new bis-quaternary isosters of 1,5-pentanediammonium dibromides","volume":"6","author":"Dev\u00ednsky","year":"1987","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2022.114632_bib50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2672.2005.02664.x","article-title":"Cationic antiseptics: diversity of action under a common epithet","volume":"99","author":"Gilbert","year":"2005","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114632_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13318-012-0086-9","article-title":"Metabolism of small antimicrobial \u03b22,2-amino acid derivatives by murine liver microsomes","volume":"37","author":"Hansen","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2022.114632_bib52","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/jo01097a026","article-title":"An extended table of hammett substituents constants based on the ionization of substituted benzoic acids","volume":"23","author":"McDaniel","year":"1958","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114632_bib54","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/molecules23071719","article-title":"Salts of therapeutic agents: chemical, physicochemical, and biological considerations","volume":"23","author":"Gupta","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114632_bib55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","article-title":"Salt formation to improve drug solubility","volume":"59","author":"Serajuddin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.114632_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5173(86)90055-4","article-title":"Salt selection for basic drugs","volume":"33","author":"Gould","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2022.114632_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/36.2.303","article-title":"Real-time measurement of cell permeabilization with low-molecular-weight membranolytic agents","volume":"36","author":"Virta","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114632_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-6968.1992.tb05705.x","article-title":"The mechanism of action of chlorhexidine","volume":"100","author":"Kuyyakanond","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2022.114632_bib59","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.26.4.546","article-title":"Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa","volume":"26","author":"Loh","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114632_bib60","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1039\/C7NP00020K","article-title":"Proline-rich antimicrobial peptides targeting protein synthesis","volume":"34","author":"Graf","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2022.114632_bib61","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bbagen.2006.09.006","article-title":"Dual mode of action of Bac7, a proline-rich antibacterial peptide","volume":"1760","author":"Podda","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2022.114632_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10989-009-9182-3","article-title":"The proline-rich antibacterial peptide Bac7 binds to and inhibits in vitro the molecular chaperone DnaK","volume":"15","author":"Scocchi","year":"2009","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.ejmech.2022.114632_bib63","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.chembiol.2014.10.009","article-title":"The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis","volume":"21","author":"Mardirossian","year":"2014","journal-title":"Chem. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:48:12Z","timestamp":1759330092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422005347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":63,"alternative-id":["S0223523422005347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114632","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A concise SAR-analysis of antimicrobial cationic amphipathic barbiturates for an improved activity-toxicity profile","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114632"}}